home / stock / rphm / rphm quote
Last: | $1.62 |
---|---|
Change Percent: | -10.5% |
Open: | $1.7 |
Close: | $1.81 |
High: | $1.73 |
Low: | $1.5501 |
Volume: | 6,300,843 |
Last Trade Date Time: | 05/13/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.62 | $1.7 | $1.81 | $1.73 | $1.5501 | 6,300,843 | 05-13-2024 |
$1.81 | $1.86 | $1.81 | $1.87 | $1.8 | 67,284 | 05-10-2024 |
$1.86 | $1.8583 | $1.86 | $1.89 | $1.83 | 83,118 | 05-09-2024 |
$1.83 | $1.75 | $1.83 | $1.89 | $1.72 | 284,836 | 05-08-2024 |
$1.74 | $1.76 | $1.74 | $1.78 | $1.71 | 118,135 | 05-07-2024 |
$1.73 | $1.72 | $1.73 | $1.77 | $1.71 | 47,121 | 05-06-2024 |
$1.74 | $1.75 | $1.74 | $1.77 | $1.72 | 110,683 | 05-03-2024 |
$1.73 | $1.71 | $1.73 | $1.75 | $1.7 | 40,609 | 05-02-2024 |
$1.71 | $1.68 | $1.71 | $1.77 | $1.67 | 107,875 | 05-01-2024 |
$1.67 | $1.66 | $1.67 | $1.7 | $1.66 | 93,297 | 04-30-2024 |
$1.67 | $1.65 | $1.67 | $1.67 | $1.64 | 171,814 | 04-29-2024 |
$1.67 | $1.7096 | $1.67 | $1.7096 | $1.66 | 115,223 | 04-26-2024 |
$1.65 | $1.68 | $1.65 | $1.68 | $1.62 | 119,607 | 04-25-2024 |
$1.68 | $1.66 | $1.68 | $1.7 | $1.66 | 138,349 | 04-24-2024 |
$1.675 | $1.67 | $1.675 | $1.7201 | $1.64 | 78,044 | 04-23-2024 |
$1.69 | $1.73 | $1.69 | $1.7364 | $1.65 | 181,894 | 04-22-2024 |
$1.74 | $1.72 | $1.74 | $1.76 | $1.7 | 82,987 | 04-19-2024 |
$1.76 | $1.78 | $1.76 | $1.78 | $1.7 | 76,424 | 04-18-2024 |
$1.77 | $1.64 | $1.77 | $1.92 | $1.64 | 348,991 | 04-17-2024 |
$1.65 | $1.63 | $1.65 | $1.7 | $1.63 | 48,695 | 04-16-2024 |
News, Short Squeeze, Breakout and More Instantly...
Reneo Pharmaceuticals Inc. Company Name:
RPHM Stock Symbol:
NASDAQ Market:
Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM) shares initially traded higher Monday before turning negative after the company announced a proposed merg...
MONSEY, N.Y., May 13, 2024 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the proposed merger of Reneo Pharmaceuti...
Merger to create a Nasdaq-listed, clinical-stage biopharmaceutical company focused on advancing OnKure's portfolio of novel precision medicin...